Home » Topics » BioWorld Science

BioWorld Science
RSS

Amgen begins first-in-human study of AMG-427 in relapsed or refractory AML

Oct. 17, 2018

Insm1 keeps hair cells in 'n' out

Oct. 17, 2018

Protecting cartilage in arthritis

Oct. 17, 2018

AD brains have splicing problem

Oct. 17, 2018

Axsome to develop AXS-12 for narcolepsy

Oct. 16, 2018

FDA clears IND for phase I trial of CK-0801 in treatment-resistant Guillain-Barre syndrome

Oct. 16, 2018

Restorbio reports additional phase IIb data on RTB-101

Oct. 16, 2018

Athenex reports initial pilot results for T-cell receptor affinity enhancing specific T-cell therapy

Oct. 16, 2018

OncoSec initiates KEYNOTE-890 phase II study of Tavo plus Keytruda for TNBC

Oct. 16, 2018

Liposome adjuvant increases the immunogenicity of malaria vaccines

Oct. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.